Industry Experts Discuss the Future of Hemp and Cannabidiol (CBD) In Natural Products Dec. 4-7 at Gaylord Palms Resort in Orlando
ORLANDO, Fla., Dec. 3, 2014 (GLOBE NEWSWIRE) — In spite of Florida’s medical marijuana Amendment 2 failing by a very narrow margin, it is clear that the discussion about access to cannabis products in Florida is far from over.
Medical Marijuana, Inc. (OTC Pink:MJNA), a leading cannabis and industrial hemp industry innovator, is proud to announce that its portfolio company HempMeds™ is carrying on the discussion by showcasing all-natural cannabidiol (CBD) hemp products at SOHO EXPO Dec. 4-7 at the Gaylord Palms Resort in Orlando. There, retail-ready hemp cannabidiol (CBD) oil products will be showcased and sampled at booths 225, 227, 324 and 326.
Also leading the discussion are Dr. “Doc Rob” Streisfeld, NMD, and Dr. John Hicks III, MD, featured guest speakers at SOHO EXPO. Streisfeld, a natural products and cannabis industry consultant states: “Cannabis in natural products is one of the industry’s fastest-growing segments. If you consider just hemp in the cannabis spectrum, it has surpassed coconut oil-based products in retail popularity as number 8 and 10 respectively. These days, consumers are demanding retail-ready cannabis products. We are very pleased to be able to address cannabis in the natural products industry and answer questions for industry attendees at SOHO EXPO. There they will learn what to expect to see on store shelves in the very near future.”
This year’s SOHO EXPO has attracted top natural products brands, more than 1,500 registered attendees and 400-plus exhibitors. Attendees interested in learning more about all-natural CBD from healthy hemp note the following:
- Dr. Streisfeld and Dr. Hicks discuss hemp CBD at the SOHO EXPO educational presentation 10:30-11:30 a.m. on Friday, Dec. 5 in room Captiva 1 & 2.
- SOHO EXPO trade show exhibit hours are:
- Saturday, Dec. 6 from 10:30 am-5:00 pm
- Sunday, Dec. 7 from 10:30 am-4:00 pm
“At HempMeds, we were sorry to see Florida’s medical marijuana Amendment 2 fail by such a narrow margin, winning the popular vote and still not getting over the hump,” states Andrew Hard, a spokesperson for HempMeds. “However, we’re happy to exhibit cannabis and CBD hemp oil products that are legal in all 50 states at SOHO EXPO and continue to drive the dialog forward, to show everyone that the cannabis industry is here to stay.”
For show admission guidelines visit the SOHO EXPO website. SOHO EXPO has been produced since 1971 by the Southeast Natural Products Association (SENPA / SoutheastNPA), a non-profit trade association, with proceeds from the show staying in the industry. The SENPA regional office works throughout the year to provide member education and support as well as serving as a state legislative watchdog.
For more information on HempMeds™ and their all-natural CBD hemp oil products, visit: www.hempmeds.com. The Company invites the public to get involved in the conversation on the expanding cannabis industry with HempMeds™ through the Company’s social media websites on Facebook and Twitter.
HempMeds™ offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds™ is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds™ is the communication hub for the Medical Marijuana Inc. portfolio of companies.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact:
Investor Relations contact:
Medical Marijuana, Inc.
Public Relations contact: